Caliber Therapeutics, Inc. — Form D/A
Caliber Therapeutics, Inc. of NEW HOPE, PA, a company, filed a Form D amendment with the SEC on 2017-09-29. The offering totals $12.0M, of which $12.0M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2017-09-29
- Form: D/A
- Accession: 0001710388-17-000002
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $12.0M
- Amount sold: $12.0M
- Minimum investment: $100K
- Investors: 121
- Date of first sale: 2017-06-13
- Revenue range: Decline to Disclose
- SEC file number: 021-289571
Issuer
- Name: Caliber Therapeutics, Inc.
- CIK: 0001710388
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 150 UNION SQUARE DRIVE, NEW HOPE, PA, 18938
- Phone: 215 862 5797
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| David Hochman | Director | Cleveland, OH |
| Geoffrey Smith | Director | Palo Alto, CA |
| David Hochman | Executive Officer | Cleveland, OH |
| Darren Sherman | Executive Officer | New Hope, PA |
Other filings by this issuer (1)
More